SCHEMBL2646478

SCHEMBL2646478

CCCc1c(C(C)C)cc(C(C)C)c(CO)c1-c1ccc(F)cc1OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
GCGR P47871 5/20 0.44
FFAR4 Q5NUL3 3/20 0.42
CYP11B1 P15538 2/20 0.39
CYP11B2 P19099 2/20 0.39
USP2 O75604 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
FFAR1 O14842 2/20 0.37
CCNT1 O60563 2/20 0.37
CDK2 P24941 2/20 0.37
CDK9 P50750 2/20 0.37
CCNA2 P20248 1/20 0.37
CCNA1 P78396 1/20 0.37
GLRA1 P23415 1/20 0.36
BRD4 O60885 1/20 0.36
CCNE1 P24864 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2648631 0.89 GCGR (0.57) L3MBTL1GCGRFFAR4CYP11B1CYP11B2
SCHEMBL2648891 0.86 L3MBTL1 (0.46) L3MBTL1GCGRFFAR4CYP11B1CYP11B2
SCHEMBL2648392 0.84 L3MBTL1 (0.40) L3MBTL1FFAR4CYP11B1CYP11B2USP2
SCHEMBL2648389 0.84 L3MBTL1 (0.40) L3MBTL1FFAR4CYP11B1CYP11B2USP2
SCHEMBL2647845 0.81 L3MBTL1 (0.43) L3MBTL1FFAR4CYP11B1CYP11B2USP2
SCHEMBL2649450 0.78 L3MBTL1 (0.47) L3MBTL1FFAR4USP2TDP1FFAR1
SCHEMBL2648294 0.78 GCGR (0.60) GCGR
SCHEMBL2648665 0.76 FFAR4 (0.47) L3MBTL1FFAR4USP2TDP1FFAR1
SCHEMBL2647410 0.75 L3MBTL1 (0.44) L3MBTL1FFAR4CYP11B1CYP11B2USP2
SCHEMBL8854960 0.74 GLRA1 (0.44) GCGRGLRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed
EP-0934274-A1 SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS Bayer Corporation (US) 1999-08-11 EP disclosed
WO-1998004528-A2 SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS BAYER CORPORATION (US) 1998-02-05 WO disclosed